Drybench Patent.

Patent and exclusivity dates from July to December 2034 for NDAs, as FDA's Orange Book lists them

Each patent and exclusivity date from July to December 2034 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured: 14 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed dates, 2034 January to June 2034

Listed patent expiry (390)

2 Jul 2034 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 10,231,964, use patent
patent.txt line 2,197
Flags
use code U-1583
Product numbers
001
2 Jul 2034 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 10,828,294, use patent
patent.txt line 2,200
Flags
use code U-1583
Product numbers
001
2 Jul 2034 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 10,835,527, use patent
patent.txt line 2,201
Flags
use code U-1583
Product numbers
001
2 Jul 2034 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 11,998,542, use patent
patent.txt line 2,205
Flags
use code U-1583
Product numbers
001
4 Jul 2034 · NDA 213793 · SETMELANOTIDE ACETATE
US 11,129,869, product patent
patent.txt line 15,270
Flags
product
Product numbers
001
7 Jul 2034 · NDA 219208 · ATRASENTAN HYDROCHLORIDE
US 10,016,393, product patent
patent.txt line 21,547
Flags
product
Product numbers
001
7 Jul 2034 · NDA 219208 · ATRASENTAN HYDROCHLORIDE
US 9,364,458, product and use patent
patent.txt line 21,556
Flags
product use code U-3980
Product numbers
001
11 Jul 2034 · NDA 217225 · AVACINCAPTAD PEGOL SODIUM
US 11,273,171, use patent
patent.txt line 19,805
Flags
use code U-3673
Product numbers
001
11 Jul 2034 · NDA 217225 · AVACINCAPTAD PEGOL SODIUM
US 11,491,176, use patent
patent.txt line 19,806
Flags
use code U-3673
Product numbers
001
11 Jul 2034 · NDA 217225 · AVACINCAPTAD PEGOL SODIUM
US 12,016,875, use patent
patent.txt line 19,807
Flags
use code U-3673
Product numbers
001
11 Jul 2034 · NDA 218784 · VORASIDENIB
US 10,172,864, substance and product patent
patent.txt lines 21,298, 21,303
Flags
substance product
Product numbers
001, 002
11 Jul 2034 · NDA 218784 · VORASIDENIB
US 12,433,895, use patent
patent.txt lines 21,301, 21,306
Flags
use code U-4286
Product numbers
001, 002
11 Jul 2034 · NDA 218784 · VORASIDENIB
US 9,579,324, substance patent
patent.txt lines 21,302, 21,307
Flags
substance
Product numbers
001, 002
14 Jul 2034 · NDA 218276 · IPTACOPAN HYDROCHLORIDE
US 10,093,663, use patent
patent.txt line 20,923
Flags
use code U-3980
Product numbers
001
14 Jul 2034 · NDA 218276 · IPTACOPAN HYDROCHLORIDE
US 10,093,663, use patent
patent.txt line 20,924
Flags
use code U-4161
Product numbers
001
14 Jul 2034 · NDA 218276 · IPTACOPAN HYDROCHLORIDE
US 9,682,968, substance and product patent
patent.txt line 20,932
Flags
substance product
Product numbers
001
17 Jul 2034 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 9,296,782, substance and product patent
patent.txt line 9,857
Flags
substance product
Product numbers
001
18 Jul 2034 · NDA 205787 · NALOXONE HYDROCHLORIDE
US 9,517,307, product and use patent
patent.txt line 5,890
Flags
product use code U-1925
Product numbers
001
18 Jul 2034 · NDA 209862 · NALOXONE HYDROCHLORIDE
US 9,517,307, product and use patent
patent.txt line 10,914
Flags
product use code U-1925
Product numbers
001
26 Jul 2034 · NDA 219876 · DORDAVIPRONE HYDROCHLORIDE
US 9,265,765, product patent
patent.txt line 22,032
Flags
product
Product numbers
001
30 Jul 2034 · NDA 205394 · RIZATRIPTAN BENZOATE
US 9,301,948, substance and product patent
patent.txt line 5,293
Flags
substance product
Product numbers
001
30 Jul 2034 · NDA 205394 · RIZATRIPTAN BENZOATE
US 9,301,948, product patent
patent.txt line 5,294
Flags
product
Product numbers
002
30 Jul 2034 · NDA 214460 · BRINCIDOFOVIR
US 9,303,051, substance and product and use patent
patent.txt line 15,805
Flags
substance product use code U-3165
Product numbers
001
30 Jul 2034 · NDA 214461 · BRINCIDOFOVIR
US 9,303,051, substance and product and use patent
patent.txt line 15,809
Flags
substance product use code U-3165
Product numbers
001
1 Aug 2034 · NDA 209606 · ENASIDENIB MESYLATE
US 10,093,654, substance and product and use patent
patent.txt lines 10,662, 10,668
Flags
substance product use code U-2087
Product numbers
001, 002
1 Aug 2034 · NDA 209606 · ENASIDENIB MESYLATE
US 9,738,625, substance patent
patent.txt lines 10,667, 10,673
Flags
substance
Product numbers
001, 002
7 Aug 2034 · NDA 209092 · RIBOCICLIB SUCCINATE
US 12,544,379, use patent
patent.txt line 9,692
Flags
use code U-3975
Product numbers
001
7 Aug 2034 · NDA 209092 · RIBOCICLIB SUCCINATE
US 12,544,380, use patent
patent.txt line 9,694
Flags
use code U-4404
Product numbers
001
7 Aug 2034 · NDA 209092 · RIBOCICLIB SUCCINATE
US 12,544,380, use patent
patent.txt line 9,695
Flags
use code U-4405
Product numbers
001
7 Aug 2034 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 12,544,380, use patent
patent.txt line 11,039
Flags
use code U-3264
Product numbers
001
7 Aug 2034 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 12,544,380, use patent
patent.txt line 11,040
Flags
use code U-3998
Product numbers
001
16 Aug 2034 · NDA 218201 · COPPER
US 11,207,209, product patent
patent.txt line 20,898
Flags
product
Product numbers
001
18 Aug 2034 · NDA 214012 · INCLISIRAN SODIUM
US 10,125,369, substance and product and use patent
patent.txt line 15,425
Flags
substance product use code U-4249
Product numbers
001
18 Aug 2034 · NDA 214012 · INCLISIRAN SODIUM
US 10,125,369, substance and product and use patent
patent.txt line 15,426
Flags
substance product use code U-4413
Product numbers
001
18 Aug 2034 · NDA 214012 · INCLISIRAN SODIUM
US 10,125,369, substance and product and use patent
patent.txt line 15,427
Flags
substance product use code U-4414
Product numbers
001
18 Aug 2034 · NDA 214012 · INCLISIRAN SODIUM
US 12,460,206, substance and product patent
patent.txt line 15,435
Flags
substance product
Product numbers
001
19 Aug 2034 · NDA 219683 · GEMCITABINE HYDROCHLORIDE
US 10,729,823, product patent
patent.txt line 21,858
Flags
product
Product numbers
001
19 Aug 2034 · NDA 219683 · GEMCITABINE HYDROCHLORIDE
US 12,447,241, product patent
patent.txt line 21,860
Flags
product
Product numbers
001
22 Aug 2034 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,688,665, use patent
patent.txt line 13,127
Flags
use code U-2736
Product numbers
001
25 Aug 2034 · NDA 217388 · EPLONTERSEN SODIUM
US 10,683,499, substance and product and use patent
patent.txt lines 19,898, 19,902
Flags
substance product use code U-2378
Product numbers
001, 002
26 Aug 2034 · NDA 212045 · NALOXONE HYDROCHLORIDE
US 10,722,510, product and use patent
patent.txt line 13,516
Flags
product use code U-3110
Product numbers
001
26 Aug 2034 · NDA 212045 · NALOXONE HYDROCHLORIDE
US 10,973,814, product and use patent
patent.txt line 13,517
Flags
product use code U-3110
Product numbers
001
26 Aug 2034 · NDA 212045 · NALOXONE HYDROCHLORIDE
US 11,135,155, product patent
patent.txt line 13,518
Flags
product
Product numbers
001
26 Aug 2034 · NDA 212045 · NALOXONE HYDROCHLORIDE
US 11,617,713, product and use patent
patent.txt line 13,519
Flags
product use code U-3110
Product numbers
001
26 Aug 2034 · NDA 212045 · NALOXONE HYDROCHLORIDE
US 11,628,139, product and use patent
patent.txt line 13,520
Flags
product use code U-3110
Product numbers
001
26 Aug 2034 · NDA 212045 · NALOXONE HYDROCHLORIDE
US 11,975,096, product patent
patent.txt line 13,521
Flags
product
Product numbers
001
26 Aug 2034 · NDA 212045 · NALOXONE HYDROCHLORIDE
US 12,414,915, product patent
patent.txt line 13,522
Flags
product
Product numbers
001
28 Aug 2034 · NDA 219407 · DONIDALORSEN SODIUM
US 9,670,492, substance patent
patent.txt line 21,729
Flags
substance
Product numbers
001
2 Sep 2034 · NDA 209347 · GANCICLOVIR
US 9,486,530, product patent
patent.txt line 10,158
Flags
product
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 10,016,443, use patent
patent.txt line 13,137
Flags
use code U-3297
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 10,376,526, product patent
patent.txt line 13,138
Flags
product
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 10,517,880, product and use patent
patent.txt line 13,139
Flags
product use code U-3297
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 10,548,907, use patent
patent.txt line 13,140
Flags
use code U-3297
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 10,561,672, product patent
patent.txt line 13,141
Flags
product
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 10,646,500, use patent
patent.txt line 13,142
Flags
use code U-3297
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 10,758,550, use patent
patent.txt line 13,143
Flags
use code U-3296
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 10,765,686, use patent
patent.txt line 13,144
Flags
use code U-3295
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 11,400,101, use patent
patent.txt line 13,145
Flags
use code U-3297
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 12,064,442, use patent
patent.txt line 13,147
Flags
use code U-3297
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 9,078,923, product and use patent
patent.txt line 13,150
Flags
product use code U-3297
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 9,370,483, product patent
patent.txt line 13,151
Flags
product
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 9,750,754, product and use patent
patent.txt line 13,152
Flags
product use code U-3297
Product numbers
001
4 Sep 2034 · NDA 211746 · MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US 9,937,189, product patent
patent.txt line 13,153
Flags
product
Product numbers
001
5 Sep 2034 · NDA 207981 · TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE
US 9,943,537, use patent
patent.txt lines 7,897, 7,909
Flags
use code U-3659
Product numbers
001, 002
5 Sep 2034 · NDA 215383 · BELZUTIFAN
US 9,908,845, substance and product and use patent
patent.txt line 16,820
Flags
substance product use code U-3201
Product numbers
001
5 Sep 2034 · NDA 215383 · BELZUTIFAN
US 9,908,845, substance and product and use patent
patent.txt line 16,821
Flags
substance product use code U-4176
Product numbers
001
5 Sep 2034 · NDA 215383 · BELZUTIFAN
US 9,908,845, substance and product and use patent
patent.txt line 16,822
Flags
substance product use code U-4195
Product numbers
001
5 Sep 2034 · NDA 215383 · BELZUTIFAN
US 9,908,845, substance and product and use patent
patent.txt line 16,823
Flags
substance product use code U-4565
Product numbers
001
5 Sep 2034 · NDA 215383 · BELZUTIFAN
US RE49948, substance and product and use patent
patent.txt line 16,824
Flags
substance product use code U-3201
Product numbers
001
5 Sep 2034 · NDA 215383 · BELZUTIFAN
US RE49948, substance and product and use patent
patent.txt line 16,825
Flags
substance product use code U-4176
Product numbers
001
5 Sep 2034 · NDA 215383 · BELZUTIFAN
US RE49948, substance and product and use patent
patent.txt line 16,826
Flags
substance product use code U-4195
Product numbers
001
5 Sep 2034 · NDA 215383 · BELZUTIFAN
US RE49948, substance and product and use patent
patent.txt line 16,827
Flags
substance product use code U-4565
Product numbers
001
9 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,376,496, use patent
patent.txt line 6,776
Flags
use code U-2610
Product numbers
001
9 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,376,496, use patent
patent.txt line 6,777
Flags
use code U-2611
Product numbers
001
9 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,376,496, use patent
patent.txt line 6,778
Flags
use code U-4548
Product numbers
001
9 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,376,496, use patent
patent.txt line 6,779
Flags
use code U-4549
Product numbers
001
9 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,933,053, use patent
patent.txt line 6,788
Flags
use code U-3090
Product numbers
001
9 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,933,053, use patent
patent.txt line 6,789
Flags
use code U-3091
Product numbers
001
9 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,933,053, use patent
patent.txt line 6,790
Flags
use code U-4544
Product numbers
001
9 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,933,053, use patent
patent.txt line 6,791
Flags
use code U-4545
Product numbers
001
12 Sep 2034 · NDA 202880 · HYDROCODONE BITARTRATE
US 10,092,559, use patent
patent.txt lines 3,423, 3,439, 3,455, 3,471, 3,487, 3,503
Flags
use code U-55
Product numbers
001, 002, 003, 004, 005, 006
12 Sep 2034 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,132,096, product patent
patent.txt lines 3,427, 3,443, 3,459, 3,475, 3,491, 3,507
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
12 Sep 2034 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,452,163, use patent
patent.txt lines 3,434, 3,450, 3,466, 3,482, 3,498, 3,514
Flags
use code U-55
Product numbers
001, 002, 003, 004, 005, 006
12 Sep 2034 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,486,451, use patent
patent.txt lines 3,435, 3,451, 3,467, 3,483, 3,499, 3,515
Flags
use code U-55
Product numbers
001, 002, 003, 004, 005, 006
12 Sep 2034 · NDA 202880 · HYDROCODONE BITARTRATE
US 9,713,611, product and use patent
patent.txt lines 3,437, 3,453, 3,469, 3,485, 3,501, 3,517
Flags
product use code U-55
Product numbers
001, 002, 003, 004, 005, 006
14 Sep 2034 · NDA 214511 · PEGULICIANINE ACETATE
US 9,763,577, substance and product and use patent
patent.txt line 15,834
Flags
substance product use code U-3890
Product numbers
001
16 Sep 2034 · NDA 209606 · ENASIDENIB MESYLATE
US 9,732,062, substance patent
patent.txt lines 10,666, 10,672
Flags
substance
Product numbers
001, 002
17 Sep 2034 · NDA 201848 · MELPHALAN HYDROCHLORIDE
US 9,707,331, product patent
patent.txt line 2,594
Flags
product
Product numbers
001
2 Oct 2034 · NDA 203567 · EFINACONAZOLE
US 10,342,875, product and use patent
patent.txt line 4,088
Flags
product use code U-2720
Product numbers
001
2 Oct 2034 · NDA 203567 · EFINACONAZOLE
US 10,828,293, use patent
patent.txt line 4,091
Flags
use code U-2720
Product numbers
001
2 Oct 2034 · NDA 203567 · EFINACONAZOLE
US 10,864,274, use patent
patent.txt line 4,093
Flags
use code U-2720
Product numbers
001
2 Oct 2034 · NDA 203567 · EFINACONAZOLE
US 11,654,139, use patent
patent.txt line 4,095
Flags
use code U-1969
Product numbers
001
2 Oct 2034 · NDA 203567 · EFINACONAZOLE
US 9,662,394, product patent
patent.txt line 4,102
Flags
product
Product numbers
001
3 Oct 2034 · NDA 212194 · GIVOSIRAN SODIUM
US 10,119,143, substance and product and use patent
patent.txt line 13,614
Flags
substance product use code U-2672
Product numbers
001
3 Oct 2034 · NDA 212194 · GIVOSIRAN SODIUM
US 11,028,392, substance and product and use patent
patent.txt line 13,617
Flags
substance product use code U-2672
Product numbers
001
6 Oct 2034 · NDA 208799 · FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US 9,066,957, product and use patent
patent.txt lines 9,524, 9,532, 9,538, 9,550, 9,564, 9,576
Flags
product use code U-645
Product numbers
001, 002, 003, 004, 005, 006
6 Oct 2034 · NDA 208799 · FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US 9,415,008, product and use patent
patent.txt lines 9,526, 9,552
Flags
product use code U-645
Product numbers
001, 004
7 Oct 2034 · NDA 209863 · TESTOSTERONE ENANTHATE
US 11,160,751, product and use patent
patent.txt lines 10,924, 10,947, 10,970
Flags
product use code U-2418
Product numbers
001, 002, 003
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 10,098,845, product and use patent
patent.txt lines 19,554, 19,616, 19,678, 19,740
Flags
product use code U-219
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 10,292,935, product and use patent
patent.txt lines 19,555, 19,617, 19,679, 19,741
Flags
product use code U-219
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 10,688,058, product and use patent
patent.txt lines 19,556, 19,618, 19,680, 19,742
Flags
product use code U-219
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 10,973,769, product and use patent
patent.txt lines 19,557, 19,619, 19,681, 19,743
Flags
product use code U-219
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 10,987,313, product and use patent
patent.txt lines 19,558, 19,620, 19,682, 19,744
Flags
product use code U-219
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 11,357,733, product patent
patent.txt lines 19,559, 19,621, 19,683, 19,745
Flags
product
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 11,622,941, product patent
patent.txt lines 19,560, 19,622, 19,684, 19,746
Flags
product
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 11,666,538, product and use patent
patent.txt lines 19,561, 19,623, 19,685, 19,747
Flags
product use code U-219
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 12,064,521, product patent
patent.txt lines 19,563, 19,625, 19,687, 19,749
Flags
product
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 12,128,141, product and use patent
patent.txt lines 19,568, 19,630, 19,692, 19,754
Flags
product use code U-219
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 12,178,918, product patent
patent.txt lines 19,569, 19,631, 19,693, 19,755
Flags
product
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 12,178,919, product and use patent
patent.txt lines 19,570, 19,632, 19,694, 19,756
Flags
product use code U-219
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 12,274,793, product patent
patent.txt lines 19,583, 19,645, 19,707, 19,769
Flags
product
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 12,303,605, product patent
patent.txt lines 19,596, 19,658, 19,720, 19,782
Flags
product
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 12,403,099, product patent
patent.txt lines 19,601, 19,663, 19,725, 19,787
Flags
product
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 12,491,164, product patent
patent.txt lines 19,614, 19,676, 19,738, 19,800
Flags
product
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 217186 · CARBIDOPA; LEVODOPA
US 12,691,074, product patent
patent.txt lines 19,615, 19,677, 19,739, 19,801
Flags
product
Product numbers
001, 002, 003, 004
7 Oct 2034 · NDA 221075 · IBERDOMIDE HYDROCHLORIDE
US RE49647, product patent
patent.txt lines 22,411, 22,418
Flags
product
Product numbers
001, 002
7 Oct 2034 · NDA 221075 · IBERDOMIDE HYDROCHLORIDE
US RE50917, use patent
patent.txt lines 22,412, 22,419
Flags
use code U-4598
Product numbers
001, 002
10 Oct 2034 · NDA 205677 · TASIMELTEON
US 10,610,511, use patent
patent.txt line 5,769
Flags
use code U-2615
Product numbers
001
10 Oct 2034 · NDA 205677 · TASIMELTEON
US 10,610,511, use patent
patent.txt line 5,770
Flags
use code U-3007
Product numbers
001
10 Oct 2034 · NDA 205677 · TASIMELTEON
US 11,141,400, use patent
patent.txt line 5,775
Flags
use code U-2615
Product numbers
001
10 Oct 2034 · NDA 205677 · TASIMELTEON
US 11,141,400, use patent
patent.txt line 5,776
Flags
use code U-3007
Product numbers
001
10 Oct 2034 · NDA 205677 · TASIMELTEON
US 11,786,502, use patent
patent.txt line 5,785
Flags
use code U-3007
Product numbers
001
10 Oct 2034 · NDA 205677 · TASIMELTEON
US 11,786,502, use patent
patent.txt line 5,786
Flags
use code U-3739
Product numbers
001
10 Oct 2034 · NDA 214461 · BRINCIDOFOVIR
US 10,112,909, use patent
patent.txt line 15,806
Flags
use code U-3165
Product numbers
001
10 Oct 2034 · NDA 214461 · BRINCIDOFOVIR
US 10,487,061, product and use patent
patent.txt line 15,807
Flags
product use code U-3165
Product numbers
001
10 Oct 2034 · NDA 214461 · BRINCIDOFOVIR
US 8,962,829, substance and product patent
patent.txt line 15,808
Flags
substance product
Product numbers
001
10 Oct 2034 · NDA 214461 · BRINCIDOFOVIR
US 9,371,344, product patent
patent.txt line 15,810
Flags
product
Product numbers
001
10 Oct 2034 · NDA 214517 · TASIMELTEON
US 10,610,511, use patent
patent.txt line 15,840
Flags
use code U-3007
Product numbers
001
10 Oct 2034 · NDA 214517 · TASIMELTEON
US 11,141,400, use patent
patent.txt line 15,843
Flags
use code U-3007
Product numbers
001
10 Oct 2034 · NDA 214517 · TASIMELTEON
US 11,786,502, use patent
patent.txt line 15,851
Flags
use code U-3007
Product numbers
001
10 Oct 2034 · NDA 217639 · ELACESTRANT HYDROCHLORIDE
US 10,071,066, use patent
patent.txt lines 20,045, 20,052
Flags
use code U-3524
Product numbers
001, 002
10 Oct 2034 · NDA 217639 · ELACESTRANT HYDROCHLORIDE
US 11,779,552, use patent
patent.txt lines 20,049, 20,056
Flags
use code U-3524
Product numbers
001, 002
12 Oct 2034 · NDA 212271 · FOSFOMYCIN DISODIUM
US 10,086,006, use patent
patent.txt line 13,650
Flags
use code U-4332
Product numbers
001
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 11,827,642, substance and product and use patent
patent.txt line 14,209
Flags
substance product use code U-3506
Product numbers
004
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 9,200,002, substance and product and use patent
patent.txt lines 14,189, 14,198, 14,206
Flags
substance product use code U-2726
Product numbers
001, 002, 003
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 9,200,002, substance and product and use patent
patent.txt lines 14,190, 14,199, 14,214, 14,222
Flags
substance product use code U-3168
Product numbers
001, 002, 004, 005
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 9,200,002, substance and product and use patent
patent.txt line 14,215
Flags
substance product use code U-3506
Product numbers
004
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 9,944,651, substance and product and use patent
patent.txt lines 14,191, 14,200, 14,207
Flags
substance product use code U-2726
Product numbers
001, 002, 003
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 9,944,651, substance and product and use patent
patent.txt lines 14,192, 14,201, 14,216, 14,223
Flags
substance product use code U-3168
Product numbers
001, 002, 004, 005
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 9,944,651, substance and product and use patent
patent.txt line 14,217
Flags
substance product use code U-3506
Product numbers
004
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 9,994,575, substance and product and use patent
patent.txt lines 14,193, 14,202, 14,208
Flags
substance product use code U-2726
Product numbers
001, 002, 003
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 9,994,575, substance and product and use patent
patent.txt lines 14,194, 14,203, 14,218, 14,224
Flags
substance product use code U-3168
Product numbers
001, 002, 004, 005
15 Oct 2034 · NDA 212608 · AVAPRITINIB
US 9,994,575, substance and product and use patent
patent.txt line 14,219
Flags
substance product use code U-3506
Product numbers
004
20 Oct 2034 · NDA 206099 · SUMATRIPTAN SUCCINATE
US 10,076,614, product patent
patent.txt line 6,270
Flags
product
Product numbers
001
23 Oct 2034 · NDA 050795 · DOXYCYCLINE HYCLATE
US 9,295,652, product and use patent
patent.txt lines 2,152, 2,156
Flags
product use code U-918
Product numbers
007, 008
23 Oct 2034 · NDA 050795 · DOXYCYCLINE HYCLATE
US 9,511,031, product patent
patent.txt lines 2,154, 2,158
Flags
product
Product numbers
007, 008
24 Oct 2034 · NDA 205552 · IBRUTINIB
US 10,463,668, use patent
patent.txt lines 5,483, 5,582
Flags
use code U-2654
Product numbers
001, 002
24 Oct 2034 · NDA 205552 · IBRUTINIB
US 10,695,350, use patent
patent.txt lines 5,493, 5,592
Flags
use code U-2846
Product numbers
001, 002
24 Oct 2034 · NDA 205552 · IBRUTINIB
US 9,795,604, use patent
patent.txt line 5,558
Flags
use code U-2150
Product numbers
001
24 Oct 2034 · NDA 205552 · IBRUTINIB
US 9,795,604, use patent
patent.txt lines 5,559, 5,656
Flags
use code U-2969
Product numbers
001, 002
24 Oct 2034 · NDA 205552 · IBRUTINIB
US 9,795,604, use patent
patent.txt lines 5,560, 5,657
Flags
use code U-2970
Product numbers
001, 002
24 Oct 2034 · NDA 205552 · IBRUTINIB
US 9,795,604, use patent
patent.txt lines 5,561, 5,658
Flags
use code U-3422
Product numbers
001, 002
24 Oct 2034 · NDA 210563 · IBRUTINIB
US 10,463,668, use patent
patent.txt lines 11,603, 11,709, 11,813, 11,917
Flags
use code U-2654
Product numbers
001, 002, 003, 004
24 Oct 2034 · NDA 210563 · IBRUTINIB
US 10,695,350, use patent
patent.txt lines 11,613, 11,719, 11,823, 11,930
Flags
use code U-2846
Product numbers
001, 002, 003, 004
24 Oct 2034 · NDA 210563 · IBRUTINIB
US 9,795,604, use patent
patent.txt lines 11,686, 11,790, 11,894
Flags
use code U-3422
Product numbers
001, 002, 003
24 Oct 2034 · NDA 210563 · IBRUTINIB
US 9,795,604, use patent
patent.txt lines 11,684, 11,788, 11,892, 12,001
Flags
use code U-2969
Product numbers
001, 002, 003, 004
24 Oct 2034 · NDA 210563 · IBRUTINIB
US 9,795,604, use patent
patent.txt lines 11,685, 11,789, 11,893, 12,002
Flags
use code U-2970
Product numbers
001, 002, 003, 004
24 Oct 2034 · NDA 217003 · IBRUTINIB
US 10,463,668, use patent
patent.txt line 19,156
Flags
use code U-2970
Product numbers
001
24 Oct 2034 · NDA 217003 · IBRUTINIB
US 10,695,350, use patent
patent.txt line 19,165
Flags
use code U-2970
Product numbers
001
24 Oct 2034 · NDA 217003 · IBRUTINIB
US 9,795,604, use patent
patent.txt line 19,225
Flags
use code U-2970
Product numbers
001
24 Oct 2034 · NDA 217003 · IBRUTINIB
US 9,795,604, use patent
patent.txt line 19,226
Flags
use code U-3422
Product numbers
001
27 Oct 2034 · NDA 212271 · FOSFOMYCIN DISODIUM
US 9,345,717, use patent
patent.txt line 13,653
Flags
use code U-4332
Product numbers
001
29 Oct 2034 · NDA 212479 · METHOTREXATE
US 11,771,701, product and use patent
patent.txt line 14,047
Flags
product use code U-3700
Product numbers
001
29 Oct 2034 · NDA 212479 · METHOTREXATE
US 11,771,701, product and use patent
patent.txt line 14,048
Flags
product use code U-3701
Product numbers
001
29 Oct 2034 · NDA 212479 · METHOTREXATE
US 11,771,701, product and use patent
patent.txt line 14,049
Flags
product use code U-3702
Product numbers
001
29 Oct 2034 · NDA 212479 · METHOTREXATE
US 11,771,701, product and use patent
patent.txt line 14,050
Flags
product use code U-3703
Product numbers
001
29 Oct 2034 · NDA 212479 · METHOTREXATE
US 11,771,701, product and use patent
patent.txt line 14,051
Flags
product use code U-3704
Product numbers
001
31 Oct 2034 · NDA 211911 · BIMATOPROST
US 9,492,316, product patent
patent.txt line 13,228
Flags
product
Product numbers
001
31 Oct 2034 · NDA 211911 · BIMATOPROST
US 9,980,974, use patent
patent.txt line 13,229
Flags
use code U-2759
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,058,518, use patent
patent.txt line 16,912
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,058,518, use patent
patent.txt lines 16,913, 17,124
Flags
use code U-4522
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,064,857, use patent
patent.txt line 16,914
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,064,857, use patent
patent.txt lines 16,915, 17,125
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,080,727, use patent
patent.txt line 16,916
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,080,727, use patent
patent.txt lines 16,917, 17,126
Flags
use code U-4520
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,092,560, use patent
patent.txt line 16,918
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,092,560, use patent
patent.txt lines 16,919, 17,127
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,092,561, use patent
patent.txt line 16,920
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,092,561, use patent
patent.txt lines 16,921, 17,128
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,105,327, use patent
patent.txt line 16,922
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,105,361, use patent
patent.txt line 16,923
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,105,361, use patent
patent.txt lines 16,924, 17,129
Flags
use code U-4522
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,251,879, use patent
patent.txt line 16,925
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,251,879, use patent
patent.txt lines 16,926, 17,130
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,463,634, use patent
patent.txt line 16,927
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,463,634, use patent
patent.txt lines 16,928, 17,131
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,512,643, use patent
patent.txt line 16,929
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,512,643, use patent
patent.txt lines 16,930, 17,132
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,548,857, use patent
patent.txt line 16,931
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,596,167, use patent
patent.txt line 16,932
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,596,167, use patent
patent.txt line 16,933
Flags
use code U-4517
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,772,850, use patent
patent.txt line 16,934
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,780,066, use patent
patent.txt line 16,936
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,780,066, use patent
patent.txt lines 16,937, 17,133
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,786,469, use patent
patent.txt line 16,938
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,786,496, use patent
patent.txt line 16,939
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,786,496, use patent
patent.txt line 16,940
Flags
use code U-4517
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,799,497, use patent
patent.txt line 16,941
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,806,710, use patent
patent.txt line 16,942
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,806,710, use patent
patent.txt line 16,943
Flags
use code U-4517
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,864,209, use patent
patent.txt line 16,944
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,874,663, use patent
patent.txt line 16,945
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,874,664, use patent
patent.txt line 16,946
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,874,665, use patent
patent.txt line 16,947
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,881,624, use patent
patent.txt line 16,948
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,881,624, use patent
patent.txt lines 16,949, 17,134
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,881,657, use patent
patent.txt line 16,950
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,894,046, use patent
patent.txt line 16,951
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,894,047, use patent
patent.txt line 16,952
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,898,453, use patent
patent.txt line 16,953
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,933,034, use patent
patent.txt line 16,955
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,945,973, use patent
patent.txt line 16,957
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,966,941, use patent
patent.txt line 16,958
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,966,941, use patent
patent.txt line 16,959
Flags
use code U-4517
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 10,966,974, use patent
patent.txt line 16,961
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,007,189, use patent
patent.txt lines 16,962, 17,135
Flags
use code U-4516
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,020,389, use patent
patent.txt line 16,963
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,058,648, use patent
patent.txt line 16,964
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,065,248, use patent
patent.txt line 16,965
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,065,248, use patent
patent.txt line 16,966
Flags
use code U-4517
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,090,300, use patent
patent.txt line 16,967
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,096,937, use patent
patent.txt line 16,968
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,123,343, use patent
patent.txt line 16,969
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,123,344, use patent
patent.txt line 16,970
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,123,344, use patent
patent.txt line 16,971
Flags
use code U-4517
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,129,826, use patent
patent.txt line 16,972
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,141,388, use patent
patent.txt line 16,973
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,141,416, use patent
patent.txt line 16,974
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,147,808, use patent
patent.txt line 16,975
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,185,515, use patent
patent.txt line 16,976
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,191,739, product and use patent
patent.txt line 16,977
Flags
product use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,191,739, product and use patent
patent.txt line 16,978
Flags
product use code U-4516
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,197,839, product and use patent
patent.txt line 16,979
Flags
product use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,197,839, product and use patent
patent.txt line 16,980
Flags
product use code U-4516
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,207,281, use patent
patent.txt line 16,981
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,207,281, use patent
patent.txt lines 16,982, 17,136
Flags
use code U-4537
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,213,521, use patent
patent.txt line 16,983
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,229,640, use patent
patent.txt line 16,984
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,234,946, use patent
patent.txt line 16,985
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,234,946, use patent
patent.txt lines 16,986, 17,137
Flags
use code U-4526
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,253,491, use patent
patent.txt line 16,987
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,253,492, use patent
patent.txt line 16,988
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,253,492, use patent
patent.txt lines 16,989, 17,138
Flags
use code U-4526
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,273,133, use patent
patent.txt line 16,990
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,273,133, use patent
patent.txt lines 16,991, 17,139
Flags
use code U-4526
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,273,134, use patent
patent.txt line 16,992
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,273,134, use patent
patent.txt lines 16,993, 17,140
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,285,118, use patent
patent.txt line 16,994
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,285,118, use patent
patent.txt lines 16,995, 17,141
Flags
use code U-4526
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,285,146, use patent
patent.txt line 16,996
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,285,146, use patent
patent.txt lines 16,997, 17,142
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,291,638, use patent
patent.txt line 16,998
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,291,638, use patent
patent.txt lines 16,999, 17,143
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,291,665, use patent
patent.txt line 17,000
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,291,665, use patent
patent.txt lines 17,001, 17,144
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,298,351, use patent
patent.txt line 17,002
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,298,352, use patent
patent.txt line 17,003
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,298,352, use patent
patent.txt lines 17,004, 17,145
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,311,534, use patent
patent.txt line 17,005
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,344,544, use patent
patent.txt line 17,006
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,344,544, use patent
patent.txt lines 17,007, 17,146
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,357,744, use patent
patent.txt line 17,008
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,357,744, use patent
patent.txt line 17,009
Flags
use code U-4517
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,364,233, use patent
patent.txt line 17,010
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,382,874, use patent
patent.txt line 17,011
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,382,874, use patent
patent.txt lines 17,012, 17,147
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,419,867, use patent
patent.txt line 17,013
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,419,867, use patent
patent.txt lines 17,014, 17,148
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,426,370, use patent
patent.txt line 17,015
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,426,370, use patent
patent.txt lines 17,016, 17,149
Flags
use code U-4526
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,426,401, use patent
patent.txt line 17,017
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,426,401, use patent
patent.txt line 17,018
Flags
use code U-4517
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,433,067, product and use patent
patent.txt line 17,019
Flags
product use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,433,067, product and use patent
patent.txt line 17,020
Flags
product use code U-4516
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,439,636, use patent
patent.txt line 17,021
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,439,636, use patent
patent.txt line 17,022
Flags
use code U-4517
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,478,468, use patent
patent.txt line 17,023
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,497,721, use patent
patent.txt line 17,024
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,510,918, use patent
patent.txt line 17,025
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,517,542, use patent
patent.txt line 17,026
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,517,543, use patent
patent.txt line 17,027
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,524,007, use patent
patent.txt line 17,028
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,524,008, use patent
patent.txt line 17,029
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,534,414, product and use patent
patent.txt line 17,030
Flags
product use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,534,414, product and use patent
patent.txt line 17,031
Flags
product use code U-4516
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,541,021, use patent
patent.txt line 17,032
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,541,048, use patent
patent.txt line 17,033
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,571,417, use patent
patent.txt line 17,034
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,571,417, use patent
patent.txt lines 17,035, 17,150
Flags
use code U-4526
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,576,909, use patent
patent.txt line 17,036
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,576,909, use patent
patent.txt line 17,037
Flags
use code U-4526
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,590,124, use patent
patent.txt line 17,038
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,590,124, use patent
patent.txt lines 17,039, 17,151
Flags
use code U-4526
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,596,627, use patent
patent.txt line 17,040
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,617,728, use patent
patent.txt line 17,041
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,617,747, use patent
patent.txt line 17,042
Flags
use code U-3563
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,617,747, use patent
patent.txt lines 17,043, 17,152
Flags
use code U-4526
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,779,579, use patent
patent.txt line 17,047
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 11,969,421, use patent
patent.txt line 17,053
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 12,109,178, use patent
patent.txt line 17,057
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,168,234, use patent
patent.txt line 17,082
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,168,234, use patent
patent.txt lines 17,083, 17,159
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,198,905, use patent
patent.txt line 17,084
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,198,905, use patent
patent.txt lines 17,085, 17,160
Flags
use code U-4520
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,205,083, use patent
patent.txt line 17,086
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,205,083, use patent
patent.txt lines 17,087, 17,161
Flags
use code U-4520
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,238,032, use patent
patent.txt line 17,088
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,238,032, use patent
patent.txt lines 17,089, 17,162
Flags
use code U-4520
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,278,095, use patent
patent.txt line 17,090
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,278,095, use patent
patent.txt lines 17,091, 17,163
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,314,462, use patent
patent.txt line 17,092
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,314,462, use patent
patent.txt lines 17,093, 17,164
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,370,513, use patent
patent.txt line 17,094
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,370,513, use patent
patent.txt lines 17,095, 17,165
Flags
use code U-4520
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,375,429, use patent
patent.txt line 17,096
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,375,429, use patent
patent.txt lines 17,097, 17,166
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,408,815, use patent
patent.txt line 17,098
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,408,815, use patent
patent.txt lines 17,099, 17,167
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,421,176, use patent
patent.txt line 17,100
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,421,176, use patent
patent.txt lines 17,101, 17,168
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,457,023, use patent
patent.txt line 17,102
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,457,023, use patent
patent.txt lines 17,103, 17,169
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,457,025, use patent
patent.txt line 17,104
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,457,025, use patent
patent.txt lines 17,105, 17,170
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,474,731, use patent
patent.txt line 17,106
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,474,731, use patent
patent.txt lines 17,107, 17,171
Flags
use code U-4520
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,486,450, use patent
patent.txt line 17,108
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,486,450, use patent
patent.txt lines 17,109, 17,172
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,700,528, use patent
patent.txt line 17,110
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,700,528, use patent
patent.txt lines 17,111, 17,173
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,700,553, use patent
patent.txt line 17,112
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,700,553, use patent
patent.txt lines 17,113, 17,174
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,707,191, use patent
patent.txt line 17,114
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,707,191, use patent
patent.txt lines 17,115, 17,175
Flags
use code U-4522
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,763,932, use patent
patent.txt line 17,116
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,763,932, use patent
patent.txt lines 17,117, 17,176
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,861,595, use patent
patent.txt line 17,118
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,861,595, use patent
patent.txt lines 17,119, 17,177
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,867,819, use patent
patent.txt line 17,120
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,867,819, use patent
patent.txt lines 17,121, 17,178
Flags
use code U-4517
Product numbers
001, 002
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,968,568, use patent
patent.txt line 17,122
Flags
use code U-3419
Product numbers
001
5 Nov 2034 · NDA 215430 · BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
US 9,968,568, use patent
patent.txt lines 17,123, 17,179
Flags
use code U-4517
Product numbers
001, 002
7 Nov 2034 · NDA 216165 · CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM
US 11,124,526, use patent
patent.txt line 18,410
Flags
use code U-3852
Product numbers
001
13 Nov 2034 · NDA 218436 · REMIBRUTINIB
US 10,457,647, use patent
patent.txt line 21,085
Flags
use code U-4280
Product numbers
001
13 Nov 2034 · NDA 218436 · REMIBRUTINIB
US 9,512,084, substance and product patent
patent.txt line 21,087
Flags
substance product
Product numbers
001
14 Nov 2034 · NDA 213687 · TRIHEPTANOIN
US 12,551,461, product patent
patent.txt line 15,195
Flags
product
Product numbers
001
14 Nov 2034 · NDA 215192 · VADADUSTAT
US 10,149,842, substance and product patent
patent.txt lines 16,516, 16,530, 16,544
Flags
substance product
Product numbers
001, 002, 003
14 Nov 2034 · NDA 215192 · VADADUSTAT
US 11,065,237, substance and product and use patent
patent.txt lines 16,517, 16,531, 16,545
Flags
substance product use code U-3876
Product numbers
001, 002, 003
14 Nov 2034 · NDA 215192 · VADADUSTAT
US 9,701,636, substance and product patent
patent.txt lines 16,527, 16,541, 16,555
Flags
substance product
Product numbers
001, 002, 003
14 Nov 2034 · NDA 215192 · VADADUSTAT
US 9,987,262, use patent
patent.txt lines 16,528, 16,542, 16,556
Flags
use code U-3876
Product numbers
001, 002, 003
19 Nov 2034 · NDA 205108 · SOTALOL HYDROCHLORIDE
US 11,850,222, use patent
patent.txt line 5,210
Flags
use code U-2096
Product numbers
001
19 Nov 2034 · NDA 205108 · SOTALOL HYDROCHLORIDE
US 11,850,222, use patent
patent.txt line 5,211
Flags
use code U-2494
Product numbers
001
21 Nov 2034 · NDA 206910 · DEFERASIROX
US 9,283,209, substance and product patent
patent.txt lines 6,842–6,844
Flags
substance product
Product numbers
001, 002, 003
22 Nov 2034 · NDA 217424 · BERDAZIMER SODIUM
US 10,258,564, use patent
patent.txt line 19,923
Flags
use code U-3797
Product numbers
001
22 Nov 2034 · NDA 217424 · BERDAZIMER SODIUM
US 10,258,564, use patent
patent.txt line 19,924
Flags
use code U-3798
Product numbers
001
22 Nov 2034 · NDA 217424 · BERDAZIMER SODIUM
US 10,258,564, use patent
patent.txt line 19,925
Flags
use code U-3799
Product numbers
001
24 Nov 2034 · NDA 209310 · MOMETASONE FUROATE
US 10,232,152, product and use patent
patent.txt line 10,071
Flags
product use code U-2272
Product numbers
001
26 Nov 2034 · NDA 205109 · FERRIC OXYHYDROXIDE
US 10,624,855, product patent
patent.txt line 5,216
Flags
product
Product numbers
001
26 Nov 2034 · NDA 205109 · FERRIC OXYHYDROXIDE
US 11,234,938, product patent
patent.txt line 5,232
Flags
product
Product numbers
001
26 Nov 2034 · NDA 205109 · FERRIC OXYHYDROXIDE
US 11,446,252, product patent
patent.txt line 5,234
Flags
product
Product numbers
001
2 Dec 2034 · NDA 214985 · DARIDOREXANT HYDROCHLORIDE
US 10,023,560, use patent
patent.txt lines 16,403, 16,406
Flags
use code U-620
Product numbers
001, 002
2 Dec 2034 · NDA 214985 · DARIDOREXANT HYDROCHLORIDE
US 9,790,208, substance and product patent
patent.txt lines 16,405, 16,408
Flags
substance product
Product numbers
001, 002
3 Dec 2034 · NDA 209500 · LUMATEPERONE TOSYLATE
US 10,960,009, use patent
patent.txt line 10,437
Flags
use code U-814
Product numbers
001
3 Dec 2034 · NDA 209500 · LUMATEPERONE TOSYLATE
US 11,026,951, use patent
patent.txt line 10,438
Flags
use code U-3274
Product numbers
001
3 Dec 2034 · NDA 209500 · LUMATEPERONE TOSYLATE
US 11,026,951, use patent
patent.txt lines 10,473, 10,504
Flags
use code U-3364
Product numbers
002, 003
3 Dec 2034 · NDA 209500 · LUMATEPERONE TOSYLATE
US 9,956,227, use patent
patent.txt lines 10,465, 10,496, 10,526
Flags
use code U-2714
Product numbers
001, 002, 003
3 Dec 2034 · NDA 215830 · RITLECITINIB TOSYLATE
US 12,077,533, use patent
patent.txt line 17,535
Flags
use code U-3994
Product numbers
001
3 Dec 2034 · NDA 215830 · RITLECITINIB TOSYLATE
US 9,617,258, substance and product patent
patent.txt line 17,537
Flags
substance product
Product numbers
001
4 Dec 2034 · NDA 208944 · AMANTADINE HYDROCHLORIDE
US 10,154,971, use patent
patent.txt lines 9,614, 9,631
Flags
use code U-2459
Product numbers
001, 002
11 Dec 2034 · NDA 214622 · INFIGRATINIB PHOSPHATE
US 10,278,969, product patent
patent.txt lines 15,892, 15,896
Flags
product
Product numbers
001, 002
11 Dec 2034 · NDA 214622 · INFIGRATINIB PHOSPHATE
US 11,160,804, product patent
patent.txt lines 15,893, 15,897
Flags
product
Product numbers
001, 002
17 Dec 2034 · NDA 206966 · ABAMETAPIR
US 10,292,389, product and use patent
patent.txt line 6,916
Flags
product use code U-2863
Product numbers
001
18 Dec 2034 · NDA 209360 · ANGIOTENSIN II ACETATE
US 10,028,995, use patent
patent.txt lines 10,177, 10,192, 10,207
Flags
use code U-2338
Product numbers
001, 002, 003
18 Dec 2034 · NDA 209360 · ANGIOTENSIN II ACETATE
US 10,493,124, use patent
patent.txt lines 10,179, 10,194, 10,209
Flags
use code U-2679
Product numbers
001, 002, 003
18 Dec 2034 · NDA 209360 · ANGIOTENSIN II ACETATE
US 11,096,983, use patent
patent.txt lines 10,184, 10,199, 10,214
Flags
use code U-3211
Product numbers
001, 002, 003
18 Dec 2034 · NDA 209360 · ANGIOTENSIN II ACETATE
US 11,096,983, use patent
patent.txt lines 10,185, 10,200, 10,215
Flags
use code U-3212
Product numbers
001, 002, 003
18 Dec 2034 · NDA 209360 · ANGIOTENSIN II ACETATE
US 11,559,559, use patent
patent.txt lines 10,187, 10,202, 10,217
Flags
use code U-3514
Product numbers
001, 002, 003
18 Dec 2034 · NDA 209360 · ANGIOTENSIN II ACETATE
US 9,220,745, use patent
patent.txt lines 10,188, 10,203, 10,218
Flags
use code U-2217
Product numbers
001, 002, 003
18 Dec 2034 · NDA 209360 · ANGIOTENSIN II ACETATE
US 9,220,745, use patent
patent.txt lines 10,189, 10,204, 10,219
Flags
use code U-2218
Product numbers
001, 002, 003
20 Dec 2034 · NDA 210872 · ISOPROPYL ALCOHOL
US 10,688,291, product and use patent
patent.txt line 12,269
Flags
product use code U-1397
Product numbers
001
23 Dec 2034 · NDA 050795 · DOXYCYCLINE HYCLATE
US 9,446,057, product and use patent
patent.txt lines 2,153, 2,157
Flags
product use code U-918
Product numbers
007, 008
23 Dec 2034 · NDA 213006 · VIBEGRON
US 8,247,415, substance and product and use patent
patent.txt line 14,567
Flags
substance product use code U-3045
Product numbers
001
23 Dec 2034 · NDA 213006 · VIBEGRON
US 8,247,415, substance and product and use patent
patent.txt line 14,568
Flags
substance product use code U-4219
Product numbers
001
23 Dec 2034 · NDA 219622 · BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
US 10,617,638, product and use patent
patent.txt lines 21,803, 21,809
Flags
product use code U-4538
Product numbers
001, 002
26 Dec 2034 · NDA 214103 · LUMASIRAN SODIUM
US 10,435,692, use patent
patent.txt line 15,536
Flags
use code U-2995
Product numbers
001
26 Dec 2034 · NDA 214103 · LUMASIRAN SODIUM
US 10,465,195, substance and product and use patent
patent.txt line 15,537
Flags
substance product use code U-2995
Product numbers
001
26 Dec 2034 · NDA 214103 · LUMASIRAN SODIUM
US 10,487,330, substance and product and use patent
patent.txt line 15,539
Flags
substance product use code U-2995
Product numbers
001
26 Dec 2034 · NDA 214103 · LUMASIRAN SODIUM
US 11,060,093, substance and product and use patent
patent.txt line 15,542
Flags
substance product use code U-2995
Product numbers
001
26 Dec 2034 · NDA 214103 · LUMASIRAN SODIUM
US 9,828,606, substance and product patent
patent.txt line 15,549
Flags
substance product
Product numbers
001
30 Dec 2034 · NDA 214200 · TRILACICLIB DIHYDROCHLORIDE
US 8,598,186, substance and product patent
patent.txt line 15,644
Flags
substance product
Product numbers
001

Pediatric exclusivity, as listed (63)

12 Jul 2034 · NDA 021660 · PACLITAXEL
US 9,511,046 with pediatric exclusivity, as listed
patent.txt line 669
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
17 Jul 2034 · NDA 217180 · RUXOLITINIB PHOSPHATE
US 11,337,927 with pediatric exclusivity, as listed
patent.txt lines 19,296, 19,349, 19,402, 19,455, 19,508
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
30 Jul 2034 · NDA 205834 · LEDIPASVIR; SOFOSBUVIR
US 10,039,779 with pediatric exclusivity, as listed
patent.txt lines 5,908, 5,942
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
30 Jul 2034 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 10,086,011 with pediatric exclusivity, as listed
patent.txt lines 8,483, 8,513
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
30 Jul 2034 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 11,116,783 with pediatric exclusivity, as listed
patent.txt lines 8,485, 8,515
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
30 Jul 2034 · NDA 208341 · SOFOSBUVIR; VELPATASVIR
US 9,757,406 with pediatric exclusivity, as listed
patent.txt lines 8,511, 8,541
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
30 Jul 2034 · NDA 209195 · SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US 11,116,783 with pediatric exclusivity, as listed
patent.txt line 9,813
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
30 Jul 2034 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 11,116,783 with pediatric exclusivity, as listed
patent.txt lines 15,576, 15,604
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
30 Jul 2034 · NDA 214187 · SOFOSBUVIR; VELPATASVIR
US 11,707,479 with pediatric exclusivity, as listed
patent.txt lines 15,578, 15,606
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
4 Aug 2034 · NDA 202992 · TERIFLUNOMIDE
US 9,186,346 with pediatric exclusivity, as listed
patent.txt lines 3,592, 3,598
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
8 Aug 2034 · NDA 207103 · PALBOCICLIB
US 10,723,730 with pediatric exclusivity, as listed
patent.txt lines 7,036, 7,040, 7,044
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
8 Aug 2034 · NDA 212436 · PALBOCICLIB
US 10,723,730 with pediatric exclusivity, as listed
patent.txt lines 13,966, 13,972, 13,978
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
17 Aug 2034 · NDA 022406 · RIVAROXABAN
US 9,539,218 with pediatric exclusivity, as listed
patent.txt lines 1,785, 1,790, 1,793
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
28 Aug 2034 · NDA 203341 · BOSUTINIB MONOHYDRATE
US 11,103,497 with pediatric exclusivity, as listed
patent.txt lines 3,770, 3,781, 3,792
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
28 Aug 2034 · NDA 217729 · BOSUTINIB MONOHYDRATE
US 11,103,497 with pediatric exclusivity, as listed
patent.txt lines 20,339, 20,349
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
14 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,420,841 with pediatric exclusivity, as listed
patent.txt line 6,780
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
14 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 11,278,622 with pediatric exclusivity, as listed
patent.txt line 6,792
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
14 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 8,968,753 with pediatric exclusivity, as listed
patent.txt line 6,808
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
14 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 9,320,740 with pediatric exclusivity, as listed
patent.txt line 6,815
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
14 Sep 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 9,872,906 with pediatric exclusivity, as listed
patent.txt line 6,822
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
14 Sep 2034 · NDA 208246 · TOFACITINIB CITRATE
US 10,639,309 with pediatric exclusivity, as listed
patent.txt line 8,382
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
002
14 Sep 2034 · NDA 208246 · TOFACITINIB CITRATE
US 11,253,523 with pediatric exclusivity, as listed
patent.txt lines 8,373, 8,384
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
14 Sep 2034 · NDA 208246 · TOFACITINIB CITRATE
US 9,937,181 with pediatric exclusivity, as listed
patent.txt line 8,378
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
14 Sep 2034 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 10,286,029 with pediatric exclusivity, as listed
patent.txt line 10,302
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
14 Sep 2034 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 11,484,534 with pediatric exclusivity, as listed
patent.txt line 10,307
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
14 Sep 2034 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 10,286,029 with pediatric exclusivity, as listed
patent.txt line 16,482
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Oct 2034 · NDA 204629 · EMPAGLIFLOZIN
US 10,258,637 with pediatric exclusivity, as listed
patent.txt lines 4,876, 4,911
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 204629 · EMPAGLIFLOZIN
US 11,090,323 with pediatric exclusivity, as listed
patent.txt lines 4,878, 4,913
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 204629 · EMPAGLIFLOZIN
US 11,813,275 with pediatric exclusivity, as listed
patent.txt line 4,881
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Oct 2034 · NDA 204629 · EMPAGLIFLOZIN
US 11,833,166 with pediatric exclusivity, as listed
patent.txt lines 4,884, 4,915
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 204629 · EMPAGLIFLOZIN
US 12,433,906 with pediatric exclusivity, as listed
patent.txt lines 4,891, 4,922
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 10,258,637 with pediatric exclusivity, as listed
patent.txt lines 6,173, 6,205
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 11,090,323 with pediatric exclusivity, as listed
patent.txt lines 6,177, 6,209
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 11,833,166 with pediatric exclusivity, as listed
patent.txt lines 6,179, 6,211
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 12,433,906 with pediatric exclusivity, as listed
patent.txt lines 6,187, 6,219
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 10,258,637 with pediatric exclusivity, as listed
patent.txt lines 6,290, 6,321, 6,352, 6,381
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,090,323 with pediatric exclusivity, as listed
patent.txt lines 6,294, 6,325, 6,356, 6,385
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,813,275 with pediatric exclusivity, as listed
patent.txt lines 6,297, 6,328
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,833,166 with pediatric exclusivity, as listed
patent.txt lines 6,299, 6,330, 6,359, 6,388
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906 with pediatric exclusivity, as listed
patent.txt lines 6,306, 6,337, 6,366, 6,395
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 10,258,637 with pediatric exclusivity, as listed
patent.txt lines 9,036, 9,068, 9,100, 9,130
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,090,323 with pediatric exclusivity, as listed
patent.txt lines 9,041, 9,073, 9,105, 9,135
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,813,275 with pediatric exclusivity, as listed
patent.txt lines 9,044, 9,076
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Oct 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,833,166 with pediatric exclusivity, as listed
patent.txt lines 9,046, 9,078, 9,108, 9,138
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,433,906 with pediatric exclusivity, as listed
patent.txt lines 9,053, 9,085, 9,115, 9,145
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 10,258,637 with pediatric exclusivity, as listed
patent.txt lines 14,226, 14,256, 14,286, 14,316
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 11,090,323 with pediatric exclusivity, as listed
patent.txt lines 14,231, 14,261, 14,291, 14,321
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
3 Oct 2034 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 11,833,166 with pediatric exclusivity, as listed
patent.txt lines 14,234, 14,264, 14,294, 14,323
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
17 Nov 2034 · NDA 204629 · EMPAGLIFLOZIN
US 9,949,997 with pediatric exclusivity, as listed
patent.txt lines 4,905, 4,936
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
17 Nov 2034 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,949,997 with pediatric exclusivity, as listed
patent.txt lines 6,318, 6,349, 6,378, 6,407
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
17 Nov 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,949,997 with pediatric exclusivity, as listed
patent.txt lines 9,063, 9,095, 9,125, 9,155
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
28 Nov 2034 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 8,906,898 with pediatric exclusivity, as listed
patent.txt line 6,806
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
28 Nov 2034 · NDA 213138 · FIDAXOMICIN
US 9,808,530 with pediatric exclusivity, as listed
patent.txt line 14,700
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
29 Nov 2034 · NDA 205437 · APREMILAST
US 10,092,541 with pediatric exclusivity, as listed
patent.txt lines 5,397, 5,409, 5,421
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
29 Nov 2034 · NDA 205437 · APREMILAST
US 9,872,854 with pediatric exclusivity, as listed
patent.txt lines 5,406, 5,418, 5,430
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
11 Dec 2034 · NDA 204629 · EMPAGLIFLOZIN
US 9,949,998 with pediatric exclusivity, as listed
patent.txt lines 4,909, 4,938
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
11 Dec 2034 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,949,998 with pediatric exclusivity, as listed
patent.txt lines 9,066, 9,098, 9,128, 9,158
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
11 Dec 2034 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,949,998 with pediatric exclusivity, as listed
patent.txt lines 14,253, 14,283, 14,313, 14,342
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
17 Dec 2034 · NDA 203389 · CYSTEAMINE BITARTRATE
US 9,173,851 with pediatric exclusivity, as listed
patent.txt lines 3,815, 3,839
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
17 Dec 2034 · NDA 203389 · CYSTEAMINE BITARTRATE
US 9,233,077 with pediatric exclusivity, as listed
patent.txt lines 3,821, 3,845
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
17 Dec 2034 · NDA 213491 · CYSTEAMINE BITARTRATE
US 9,173,851 with pediatric exclusivity, as listed
patent.txt lines 15,030, 15,054
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
17 Dec 2034 · NDA 213491 · CYSTEAMINE BITARTRATE
US 9,233,077 with pediatric exclusivity, as listed
patent.txt lines 15,036, 15,060
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
22 Dec 2034 · NDA 206192 · COBIMETINIB FUMARATE
US 11,087,354 with pediatric exclusivity, as listed
patent.txt line 6,435
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001

Non-patent exclusivity (1)

25 Oct 2034 · NDA 213972 · PROBENECID; SULOPENEM ETZADROXIL
GAIN exclusivity
exclusivity.txt line 1,281
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001